Stock Price
1,330.00
Daily Change
-3.30 -0.25%
Monthly
-9.39%
Yearly
-9.66%
Q1 Forecast
1,299.11

Cipla reported INR29.1B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
aTyr Pharma USD 22.13M 6.75M Sep/2025
Cipla INR 29.1B 1.16B Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
UPL INR 66.73B 1.49B Dec/2025